Home » Stocks » China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc. (SXTC)

Stock Price: $0.379 USD -0.011 (-2.92%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
After-hours: $0.377 -0.001 (-0.32%) Aug 11, 7:54 PM

Stock Price Chart

Key Info

Market Cap 22.77M
Revenue (ttm) 5.16M
Net Income (ttm) -10.29M
Shares Out 27.73M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $0.379
Previous Close $0.390
Change ($) -0.011
Change (%) -2.92%
Day's Open 0.390
Day's Range 0.375 - 0.391
Day's Volume 2,355,691
52-Week Range 0.340 - 2.950

More Stats

Market Cap 22.77M
Enterprise Value 20.62M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 27.73M
Float 11.73M
EPS (basic) -0.416
EPS (diluted) -0.42
FCF / Share 0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 2.32%
Payout Ratio n/a
Shares Short 853,609
Short Ratio 0.01
Short % of Float 0.70%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 43.15
PS Ratio 4.41
PB Ratio 2.55
Revenue 5.16M
Operating Income -1.26M
Net Income -10.29M
Free Cash Flow 527,589
Net Cash 2.15M
Net Cash / Share 0.04
Gross Margin 52.37%
Operating Margin -24.33%
Profit Margin -3,113.50%
FCF Margin 10.22%
ROA -4.28%
ROE -100.33%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth55.75%-83.89%80.04%-
Gross Profit2.792.614.933.30
Operating Income-1.26-
Net Income-10.291.541.191.19
Shares Outstanding24.7320.5720.0020.00
Earnings Per Share-0.420.080.060.06
EPS Growth-27.12%0%-
Operating Cash Flow0.930.241.920.29
Capital Expenditures-0.41-0.60-1.03-0.18
Free Cash Flow0.53-0.360.890.11
Cash & Equivalents8.879.370.960.07
Total Debt6.720.300.390.30
Net Cash / Debt2.159.070.58-0.24
Book Value9.4011.113.291.85
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name China SXT Pharmaceuticals, Inc.
Country China
CEO Feng Zhou

Stock Information

Ticker Symbol SXTC
Stock Exchange NASDAQ
Unique Identifier NASDAQ: SXTC
IPO Date January 4, 2019


China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it serves 116 pharmaceutical companies, 56 pharmacies and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China.